HAEGTFTSD
BR
- Product Code: 105935
| Molecular Weight: | 963.96 g./mol | Molecular Formula: | |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
HAEGTFTSD is a peptide sequence that has gained attention in the field of biomedical research, particularly in the study of diabetes and metabolic disorders. It is closely related to glucagon-like peptide-1 (GLP-1), a hormone that plays a critical role in regulating blood sugar levels. This peptide is being explored for its potential therapeutic applications in managing type 2 diabetes, as it can enhance insulin secretion, suppress glucagon release, and slow gastric emptying. Additionally, it is being investigated for its potential to promote weight loss, making it a candidate for obesity treatment. Researchers are also studying its effects on cardiovascular health, as GLP-1 analogs have shown promise in reducing the risk of heart disease. Its application in drug development focuses on creating long-acting formulations to improve patient compliance and treatment outcomes.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿41,760.00 |
+
-
|
HAEGTFTSD
HAEGTFTSD is a peptide sequence that has gained attention in the field of biomedical research, particularly in the study of diabetes and metabolic disorders. It is closely related to glucagon-like peptide-1 (GLP-1), a hormone that plays a critical role in regulating blood sugar levels. This peptide is being explored for its potential therapeutic applications in managing type 2 diabetes, as it can enhance insulin secretion, suppress glucagon release, and slow gastric emptying. Additionally, it is being investigated for its potential to promote weight loss, making it a candidate for obesity treatment. Researchers are also studying its effects on cardiovascular health, as GLP-1 analogs have shown promise in reducing the risk of heart disease. Its application in drug development focuses on creating long-acting formulations to improve patient compliance and treatment outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :